Development of a Serum Metabolome‐Based Test for Early‐Stage Detection of Multiple Cancers
Cancer Reports · 2024-11 · 7 (11)
DOI: 10.1002/cnr2.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 19.11.2024. Verfasst von Rajnish Nagarkar und 9 weiteren Autor:innen. Beteiligte Einrichtung: HCG Manavta Cancer Centre, Nashik, Maharashtra, India. Hauptthemen laut MEDLINE: Early Detection of Cancer, Metabolome, Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Detection of cancer at the early stage currently offers the only viable strategy for reducing disease‐related morbidity and mortality. Various approaches for multi‐cancer early detection are being explored, which largely rely on capturing signals from circulating analytes shed by tumors into the blood. The fact that biomarker concentrations are limiting in the early stages of cancer, however, compromises the accuracy of these tests. We, therefore, adopted an alternate approach that involved interrogation of the serum metabolome with machine learning‐based data analytics. Here, we monitored for modulations in metabolite patterns that correlated with the presence or absence of cancer. Results obtained confirmed the efficacy of this approach by demonstrating that it could detect a total of 15 cancers in women with an average accuracy of about 99%.
Aims
To further increase the scope of our test, we conducted an investigator‐initiated clinical trial involving a total of 6445 study participants, which included both cancer patients and non‐cancer volunteers. Our goal here was to maximize the number of cancers that could be detected, while also covering cancers in both females and males. Methods and Results Metabolites extracted from individual serum samples were profiled by ultra‐performance liquid chromatography coupled to a high‐resolution mass spectrometer using an untargeted protocol. After processing, the data were analyzed by our cancer detection machine‐learning algorithm to differentiate cancer from non‐cancer samples. Results revealed that our test platform could indeed detect a total of 30 cancers, covering both females and males, with an average accuracy of ~98%. Importantly, the high detection accuracy remained invariant across all four stages of the cancers.
Conclusion
Thus, our approach of integrating untargeted metabolomics with machine learning‐powered data analytics offers a powerful strategy for early‐stage multi‐cancer detection with high accuracy. Trial Registration: Registration No: CTRI/2023/03/050316
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HCG Manavta Cancer Centre, Nashik, Maharashtra, India.
- HealthCare Global Enterprises Limited, City Cancer Centre, Vijayawada, India.
- Indoriv Clinical, Kolkata, India.
- Department of Radiotherapy, IPGME&R, Kolkata, India.
- PredOmix Technologies Private Limited, Gurugram, India.
- PredOmix Health Sciences Private Limited, Singapore, Singapore.
ORCID-Profile: Suparna Kanti Pal, Zaved Siddiqui
Zitieren
APA
Nagarkar, R., Gopichand, M., Pal, S. K., Gupta, A., Saquib, N. M., Ahmad, A., Sagar, G., Rao, K. V. S., Siddiqui, Z., & Longkumer, I. (2024). Development of a Serum Metabolome‐Based Test for Early‐Stage Detection of Multiple Cancers. Cancer Reports, 7(11). https://doi.org/10.1002/cnr2.70042
Vancouver
Nagarkar R, Gopichand M, Pal SK, Gupta A, Saquib NM, Ahmad A, et al. Development of a Serum Metabolome‐Based Test for Early‐Stage Detection of Multiple Cancers. Cancer Reports. 2024;7(11). doi:10.1002/cnr2.70042
BibTeX
@article{Nagarkar2024,
author = {Nagarkar, Rajnish and Gopichand, Mamillapalli and Pal, Suparna Kanti and Gupta, Ankur and Saquib, Najmuddin Md and Ahmad, Ahmad and Sagar, Ganga and Rao, Kanury V S and Siddiqui, Zaved and Longkumer, Imliwati},
title = {Development of a Serum Metabolome‐Based Test for Early‐Stage Detection of Multiple Cancers},
journal = {Cancer Reports},
year = {2024},
volume = {7},
number = {11},
doi = {10.1002/cnr2.70042}
}
EUVIMED